CDC: Cancer Screening ‘Considerably’ Below Targets

HealthDay News — From 2000 to 2015 there were increases in colorectal cancer screening use, but not in breast or cervical cancer screening, according to a report published in the March 3 issue of the U.S. Centers for Disease Control and Prevention’s Morbidity and Mortality Weekly Report.

In order to examine progress toward meeting the Healthy People 2020 (HP2020) objectives for breast, cervical, and colorectal cancer screening, Arica White, PhD, from the CDC in Atlanta, and colleagues analyzed 2015 National Health Interview Survey data and measured cancer screening test use against national targets.

The researchers found that screening test use remained considerably below HP2020 targets for selected cancer screening tests. There was an increase in colorectal cancer screening use from 2000 to 2015 but no improvements in breast and cervical cancer screening test use. Disparities were seen in use of screening tests based on race/ethnicity, socioeconomic status, and health care access indicators. 

“Increased measures to implement evidence-based interventions and conduct targeted outreach are needed if the HP2020 targets for cancer screening are to be achieved and the disparities in screening test use are to be reduced,” the authors write.

Abstract/Full Text